Related Experiment Videos

Ultrastructural changes in skeletal muscles of rats treated neonatally with 6-mercaptopurine

Insights

This study examined muscle damage in young rats treated with 6-mercaptopurine monohydrate (6-MP). 6-MP caused early muscle fiber disorganization, primarily affecting Z-bands and myofibrils.

Area of Science:

  • Muscle physiology
  • Toxicology
  • Developmental biology

Background:

  • 6-mercaptopurine monohydrate (6-MP) is an immunosuppressant drug.
  • Understanding drug-induced myopathy is crucial for patient safety.
  • Early developmental stages may exhibit unique sensitivities to xenobiotics.

Purpose of the Study:

  • To investigate the ultrastructural muscle changes in young rats exposed to 6-mercaptopurine monohydrate.
  • To determine the onset and progression of 6-MP-induced myopathy during early development.

Main Methods:

  • Rats (2- and 6-month-old) were administered 6-mercaptopurine monohydrate (2 mg base/kg) daily from 2 to 22 days of age.
  • Muscle tissue was analyzed using electron microscopy to identify ultrastructural alterations.

Main Results:

  • Subsarcolemmal alterations, including Z-band disorganization and myofibril loss, were observed early.
  • Extensive lesions showed complete fiber involvement with vacuoles within disorganized fibrils.
  • Peripheral nerves and blood vessels remained unaffected, indicating a primary muscle pathology.

Conclusions:

  • 6-mercaptopurine monohydrate induces significant ultrastructural changes in developing rat muscles.
  • The observed myopathy is primarily myogenic, originating within the muscle fibers themselves.
  • These findings highlight the potential for 6-MP to cause muscle toxicity during early life stages.

Related Concept Videos